Histamine H3-receptor ligands and their therapeutic application
US8017646B2 · kind B2 · utility
0Cited by
15References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2006 |
| Grant date | Sep 13, 2011 |
| Priority date | — |
| Expiry date | Jul 28, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D319/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present patent application concerns new compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a saturated nitrogen-containing ring, A is a saturated C1-4 alkylene and B a C3-4 alkylene or alkenylene chain; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.